中国药业2025，Vol.34Issue(16)：1-7,7.DOI:10.3969/j.issn.1006-4931.2025.16.001
京津冀生物医药产业政策三维量化比较
Three Dimensional Quantitative Comparison of Biopharmaceutical Industry Policies in the Beijing-Tianjin-Hebei Region
摘要
Abstract
Objective To analyze the policy characteristics and differences of the biopharmaceutical industry in the Beijing-Tianjin-Hebei region.Methods The Laws and Regulations Database-Chinalawinfo was used and searched for policy texts related to the biopharmaceutical industry published from 2014 to 2024 on the websites of provincial and municipal government departments such as Beijing,Tianjin,Hebei Provincial People's Government,and drug administrations.A three dimensional policy quantification analysis framework of provinces and cities-segmented fields-policy instruments was constructed,and the external characteristics,segmented fields,and policy instruments of provincial and municipal biopharmaceutical policies issued by the three places in the past decade were analyzed.Results A total of 290 policies were included,including 104 policies in Beijing,107 policies in Tianjin,and 79 policies in Hebei.The overall number of publications in each year of the three places first increased and then decreased,and reached peak in 2020.Provincial and municipal governments were the main institutions for policy release,but there were relatively few joint policy released among the three places(only one policy).Environmental-type policy instruments were the most frequently used,with planning layout(245 times,89.48%),market building(205 times,70.69%),and supervision and management(177 times,61.03%)tools being more commonly used.The policy instruments in policies released from 2016 to 2017 were more intensively used,and since then,the density had shown a fluctuating decrease.In the segmented fields,there were more policies on drugs and biological products in Beijing,more medical devices in Tianjin,and more traditional Chinese medicine in Hebei.Supply side and demand side tools were more commonly used in policies related to biological products fields,while environmental tools were more commonly used in the fields of medical devices and pharmaceuticals.Conclusion The frequency of policies released in the Beijing-Tianjin-Hebei region was relatively similar,and had formed a differentiated pattern in segmented fields.Industrial policies should be based on a scientific supply and guarantee system environment,using more demand driven tools to assist in the development and cultivation of domestic and international markets,and improving synergy through joint publications by the region.关键词
生物医药产业/京津冀/政策工具/量化分析Key words
biopharmaceutical industry/Beijing-Tianjin-Hebei region/policy instruments/quantification analysis分类
医药卫生引用本文复制引用
严舒,张婷,欧阳昭连..京津冀生物医药产业政策三维量化比较[J].中国药业,2025,34(16):1-7,7.基金项目
北京市社会科学基金项目(重点项目)[24JCB024]. （重点项目）
